ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Net Cash Flow of -$405903.0 for Q1 2026, up 65.15% YoY from -$245783.2 in Q1 2025, and down 1181.58% sequentially from -$31672.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Net Cash Flow across 11 years of filings, most recently posting -$405903.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 65.15% year-over-year to -$405903.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 283.67% YoY), while the FY2025 annual figure was -$2.5 million, down 723.68% from the prior year.
- Net Cash Flow eased to -$405903.0 in Q1 2026, from -$31672.0 in the prior quarter.
- Over the last five years, Net Cash Flow for NDRA reached as high as $5.3 million in Q2 2024 and fell as low as -$3.3 million in Q3 2022.
- The 5-year median for Net Cash Flow is -$1.2 million (2025), against an average of -$535592.4.
- Annual changes were most pronounced in 2022 — Net Cash Flow surged 248.27% — and 2024, when it sank 202.76%.
- A 5-year view of Net Cash Flow shows it stood at -$3.1 million in 2022, then soared by 83.99% to -$500629.0 in 2023, then slumped by 202.76% to -$1.5 million in 2024, then soared by 97.91% to -$31672.0 in 2025, then sank by 1181.58% to -$405903.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$405903.0, -$31672.0, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -121.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -6.68 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.12 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 21.27 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 11.79 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 56.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -11.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -328.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -5.89 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | -405,903.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -405,903.00 |
| Mar 31, 2026 | -405,903.00 |
| Dec 31, 2025 | -31,672.00 |
| Dec 31, 2025 | -31,672.00 |
| Sep 30, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -256,300.00 |
| Jun 30, 2025 | -256,300.00 |
| Mar 31, 2025 | -1.16 Mn |
| Mar 31, 2025 | -1.16 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Dec 31, 2023 | -500,629.00 |
| Dec 31, 2023 | -500,629.00 |
| Sep 30, 2023 | -1.48 Mn |
| Sep 30, 2023 | -1.48 Mn |